Georgios Zarkavelis

TL;DR: It is of major importance to investigate further and collect sufficient evidence, aiming to guide patients and physicians in everyday clinical practice, in order to maintain ovarian function and fertility in female cancer survivors.

TL;DR: The FOLFIRI + aflibercept regimen is active and tolerable; however, it failed to improve historical benchmarks of efficacy in chemonaive patients with mCRC, suggesting that this regimen has cytoreductive activity in disease with adverse biology.

TL;DR: A present international oncologists' panel, ECPC and FAVO, strongly suggest that Hospital measures in a specific geographical area/Nation should be in line with the local epidemic, and restrictions adopted should be adapted and stratified over time.

TL;DR: The magnitude of cancer cachexia recommendations for physicians on the Web at a global level was scant both for coverage and consistency, and at any time-point considered, and Continent, national highest developmental index, oncology tradition and economic-geographic areas were not found to influence Web guideline provision.